Squamous cell carcinoma is the second most common type of skin cancer after basal cell carcinoma. The cancer is characterized by uncontrolled growth of squamous cells that are found in the middle and outer epidermal layers of the skin. Squamous cell carcinoma of the skin is also referred as cutaneous cell carcinoma to differentiate it from the other types of squamous cell carcinomas including squamous-cell carcinoma of the lung, squamous cell thyroid carcinoma, esophageal squamous cell carcinoma, and squamous-cell carcinoma of the vagina. Squamous cell carcinoma is generally caused due to excessive exposure of skin to the harmful ultraviolet rays of sun. However, a number of other factors are being related to elevated risks of developing squamous cell carcinoma including old age, genetic inheritance, Caucasian features including light skin color, red or blonde hair, blue, green colored eyes, exposure to radiations, excessive use of tanning beds or UV lamps, and HIV, HPV or AIDS infection. Squamous cell carcinoma is a relatively slow growing skin cancer compared to other skin malignancies; however, if not detected at an early stage, the cancer can metastasize to other organs of the body such as lungs, bones, and lymph nodes, and become hard to treat. Squamous cell carcinoma can occur in any part of the body including the mucosal linings of mouth, anus, and genitals. It generally begins with firm, flat or raised, red nodules with a rough scaly skin. The patch can turn into a sore, bleeding patch, or wart-like sore with disease progression.
Need an Overview of the Report on Squamous Cell Carcinoma Treatment Market? Ask for the Brochure here
Global Squamous Cell Carcinoma Treatment Market: Dynamics
Rise in Prevalence of Non-melanoma Skin Cancer due to Environmental Factors Boosts Market
The global squamous cell carcinoma treatment market is anticipated to grow at a steady pace during the forecast period owing to a multitude of factors. Changes in environment increase the incidence of numerous cutaneous malignancies including non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma). Depletion of the ozone layer of atmosphere increases the penetration by harmful UV rays of the sun. Prolonged exposure to the sun and factors such as fair complexion, exposure to chemical carcinogens such as arsenic, and genetic factors elevate the risk of developing squamous cell carcinoma. These environmental factors increase the rate of prevalence of squamous cell carcinoma, especially among Caucasians, thereby driving the global squamous cell carcinoma treatment market. Surge in the geriatric population, rise in initiatives to create disease awareness, and favorable reimbursement scenario boost the demand for squamous cell carcinoma treatment measures. However, high cost of the treatment and lack of awareness in developing countries are anticipated to hamper the growth of the global squamous cell carcinoma treatment market in the next few years.
Global Squamous Cell Carcinoma Treatment Market - Competitive Landscape
Major players operating in the global squamous cell carcinoma treatment market include Regeneron Pharmaceuticals, Inc., Sanofi, and Mylan N.V.
Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Squamous Cell Carcinoma Treatment Market” here
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company with medicines and pipeline designed to treat eye diseases, allergic & inflammatory diseases, cancer, cardiovascular & metabolic diseases, neuromuscular diseases, infectious diseases, and rare diseases. The company’s recently approved Libtayo (cemiplimab-rwlc) is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
Sanofi is a multinational pharmaceutical company headquartered in Paris, France. The company provides services in more than 170 countries. It provides products across seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. Sanofi’s subsidiary under the name Sanofi Pasteur is one of the largest producers of life saving vaccines in the world.
Global Squamous Cell Carcinoma Treatment Market: Segmentation
The global squamous cell carcinoma treatment market can be segmented based on:
- Treatment Type
In terms of treatment type, the global market can be classified into:
- Surgical Treatments
- Surgical Excision
- Electrodesiccation & Curettage (Ed&C)
- Mohs Surgery
- Topical Treatment
- Targeted Therapy
- Radiation Therapy
- Photodynamic Therapy (Pdt)
- Laser Therapy
Based on end-user, the global market can be divided into:
- Specialty Clinics
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.